AAME vs ORGN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 04, 2026

AAME

30.6
AI Score
VS
ORGN Wins

ORGN

53.7
AI Score

Investment Advisor Scores

AAME

31score
Recommendation
AVOID NEW MONEY

ORGN

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AAME ORGN Winner
Forward P/E 7.391 0 Tie
PEG Ratio 2.4344 0 Tie
Revenue Growth 20.8% -91.2% AAME
Earnings Growth -78.4% 266.7% ORGN
Tradestie Score 30.6/100 53.7/100 ORGN
Profit Margin 2.5% 0.0% AAME
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD ORGN

Relative Price Performance (Last 90 Days)

AAME 1M: -7.4% · 3M: -25.0% ORGN 1M: -32.1% · 3M: -58.3%

Current Technical Phase

AAME

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.5%), weak momentum, RSI 40

RSI (14): 39.7 · Price: $1.26

ORGN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -27.3%), weak momentum, RSI 34

RSI (14): 33.5 · Price: $0.95

Fundamentals Snapshot

Metric AAME ORGN
Market Cap — —
Forward P/E 7.4 -3.1
Trailing P/E 5.5 —
Revenue (TTM) — —
Revenue Growth 0.2% -0.9%
Gross Margin 0.1% 0.0%
Operating Margin 0.0% -34.6%
EPS 0.23 -48.43
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ORGN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.